Profile
Matthew Bartholomae is Secretary & General Counsel at Cartesian Therapeutics, Inc. since 2023.
Formerly, Secretary & General Counsel at Selecta Biosciences, Inc. from 2020 to 2023, and Counsel at Minerva Neurosciences, Inc. from 2016 to 2018.
Education includes undergraduate studies at Boston College and graduate studies at the University of New Hampshire School of Law.
Matthew Bartholomae active positions
| Companies | Position | Start |
|---|
Former positions of Matthew Bartholomae
| Companies | Position | End |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | General Counsel | 01/11/2023 |
| MINERVA NEUROSCIENCES, INC. | Corporate Officer/Principal | 01/01/2018 |
Training of Matthew Bartholomae
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
University of New Hampshire School of Law
University of New Hampshire School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Matthew Bartholomae
















